After HLA‐B*15:02 screening, the residual risk of carbamazepine‐induced nonimmediate cutaneous adverse reactions is 0.059. Among these HLA‐B*15:02‐negative cases, HLA‐B*15:11 and HLA‐B*15:21 carrier status significantly increases the risk of carbamazepine‐induced nonimmediate cADR.
Warit Ruanglertboon +11 more
wiley +1 more source
The role of nanoparticles in the treatment of diabetic foot ulcers: mechanisms, delivery platforms, translational challenges, and future directions. [PDF]
Eze ED +3 more
europepmc +1 more source
Aims This study aimed to analyse clinical investigation‐device initial submissions received by the MHRA between January 2022 and December 2025. Methods Data on submissions were extracted from the clinical investigations unit data bank; software as medical devices were not included. The predefined primary end‐point was submission type.
Andrea Manfrin +7 more
wiley +1 more source
Adjunctive Autologous Platelet-Rich Plasma Activated with Autologous Thrombin Serum for a Refractory Below-Knee Amputation Stump Wound: A Case Report. [PDF]
Shara K +5 more
europepmc +1 more source
Dressing-Change Frequency in Acute Hand Burns: A Narrative Review of Healing, Infection Risk, Pain, Scar Quality, and Functional Recovery. [PDF]
Azeem A +3 more
europepmc +1 more source
Hydrogels in the Management of Peripheral Venous Disease: Bridging Material Design and Clinical Evidence. [PDF]
Silosi CA +3 more
europepmc +1 more source
Effectiveness of negative pressure wound therapy versus conventional dressings in emergency laparotomy: a systematic review and meta-analysis of randomized controlled trials. [PDF]
Antonini FS +12 more
europepmc +1 more source
Therapeutic potential of herbal topical agents in evidence-based wound care: a systematic research review. [PDF]
Kumari R +7 more
europepmc +1 more source

